Objective: Postmenopausal squamous atypia (PSA) mimics squamous intraepithelial lesion (SIL). We investigate the PSA contribution to the atypical squamous cells of undetermined significance (ASCUS) pool, its cytologic features and Hybrid Capture 2 (HC2) relative light unit/cutoff (RLU/CO) values. Study Design: 658 ASCUS Pap tests in women ≥55 years were reviewed to select those with koilocyte-like cells and/or atypical parakeratosis. Follow-up was positive when a biopsy showed SIL or carcinoma or a later HC2 test was positive. Results: Sixty-nine cases (10.5%) were selected. Forty-two (60.9%) were HC2 negative, and 27 (39.1%) were HC2 positive. Follow-up was available for 23 (54.7%) HC2-negative and 19 (70.3%) HC2-positive cases. No HC2-negative (0%) and 8 HC2-positive (42.1%) cases were positive on follow-up. Within cases negative on follow-up, 3 were PSA on biopsy. PSA was characterized by perinuclear halos, mild nuclear enlargement, smooth nuclear contours, and smooth chromatin. PSA-associated RLU/CO values were 0.25–2.95. Cases with SIL or carcinoma had RLU/CO values from 3.78 to 1,241.59. Conclusions: PSA contributes 0.5–2.3% to the ASCUS pool in women ≥55 years old. HC2 testing with RLU/CO of ≥1 may result in PSA occasionally testing positive. A different cutoff is not recommended but awareness of this caveat is important.

Keywords:
Pap test, Atypical squamous cells, Human papillomavirus, Hybrid Capture 2 hpv, Postmenopausal women, Atrophy
1.
Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP: Postmenopausal squamous atypia: a spectrum including “pseudokoilocytosis.” Mod Pathol 1995; 8: 408–412.
2.
Saad RS, Kanbour-Shakir A, Lu E, Modery J, Kanbour A: Cytomorphologic analysis and histological correlation of high-grade squamous intraepithelial lesions in postmenopausal women. Diagn Cytopathol 2006; 34: 467–471.
3.
Cibas ES, Browne TJ, Bassichis MH, Lee KR: Enlarged squamous cell nuclei in cervical cytologic specimens from perimenopausal women (“PM cells”): a cause of ASC overdiagnosis. Am J Clin Pathol 2005; 124: 58–61.
4.
Johnston EI, Logani S: Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human papillomavirus DNA testing. Cancer 2007; 111: 160–165.
5.
Wied GL: Symposium on hormonal cytology. Acta Cytol 1968; 12: 87–127.
6.
Abati A, Jaffurs W, Wilder AM: Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 1998; 84: 218–225.
7.
Nayar R, Wilbur DC: The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes, ed 3. New York, Springer, 2015.
8.
Wright TC, Cox JT, Massad LS, Twiggs LE, Wilkinson EJ: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120–2129.
9.
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW: 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121: 829–846.
10.
Richards A, Dalrymple C: Abnormal cervicovaginal cytology, unsatisfactory colposcopy and the use of vaginal estrogen cream: an observational study of clinical outcomes for women in low estrogen states. J Obstet Gynaecol 2015; 41: 440–444.
11.
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA 2007; 297: 813–819.
12.
Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Munoz N: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677–2684.
13.
Castle PE, Schiffman M, Herrero R, Hildes heim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD: A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1808–1816.
14.
Hybrid Capture® 2 High-Risk HPV DNA TestTM: an in vitro nucleic acid hybridization assay with signal amplification using microplate chemiluminescence for the qualitative detection of human papillomavirus (HPV) types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 in cervical specimens. Gaithersburg, Digene Corporation, 2004.
15.
Rebolj M, Bonde J, Njor SH, Lynge E: Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ 2011; 342:d2757.
16.
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N: Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008; 100: 492–501.
17.
Sargent A, Bailey A, Turner A, Almonte M, Gilham C, Baysson H, Peto J, Roberts C, Thomson C, Desai M, Mather J, Kitchener H: Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol 2010; 48: 554–558.
18.
Knoepp SM, Kuebler DL, Wilbur DC: Correlation between hybrid capture II high-risk human papilloma virus DNA test chemiluminescence intensity from cervical samples with follow-up histologic results: a cytologic/histologic review of 367 cases. Cancer Cytopathol 2010; 118: 209–217.
19.
Elkins CT, de Vries CE, Stephens J, Suarez AA: Hybrid capture 2 test results after an initial equivocal RLU/CO value are dependent on age. Am J Clin Pathol 2013; 139: 605–610.
20.
De Vries E, Shen R, Stephens J, Suarez AA: Equivocal and weakly positive hybrid capture 2 tests in women aged 50 and older. Diagn Cytopathol 2012; 40: 708–712.
21.
Jarboe EA, Venkat P, Hirsch MS, Cibas ES, Crum CP, Garner EI: A weakly positive human papilloma virus hybrid capture II result correlates with a significant lower risk of cervical intraepithelial neoplasia 2, 3 after atypical squamous cells of undetermined significance cytology. J Low Genit Tract Dis 2010; 14: 174–178.
22.
Sherman ME, Schiffman M, Cox JT: Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002; 94: 102–107.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.